Sort
8,912 grants matching “sars cov 2”
Sequence-function relationship of influenza broadly neutralizing antibodies
$459,505Nicholas C. Wu · University Of Illinois At Urbana-Champaign · R01 · FY2024 · AI
Sequence-function relationship of influenza broadly neutralizing antibodies
$459,505Nicholas C. Wu · University Of Illinois At Urbana-Champaign · R01 · FY2023 · AI
Sequence-function relationship of influenza broadly neutralizing antibodies
$459,505Nicholas C. Wu · University Of Illinois At Urbana-Champaign · R01 · FY2025 · AI
Sequence-function relationship of influenza broadly neutralizing antibodies
$459,505Nicholas C. Wu · University Of Illinois At Urbana-Champaign · R01 · FY2022 · AI
Modeling the Coupled Dynamics of COVID-19 Transmission and Protective Behaviors
$459,154Andrew Parker · Rand Corporation · R01 · FY2025 · AI
A Longitudinal Study of COVID-19 Sequelae and Immunity
$459,134Michael C Sneller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Statistical innovation to integrate sequences and phenotypes for scalable phylodynamic inference
$459,019Marc A. Suchard · University Of California Los Angeles · R01 · FY2024 · AI
Statistical innovation to integrate sequences and phenotypes for scalable phylodynamic inference
$459,019Marc A. Suchard · University Of California Los Angeles · R01 · FY2023 · AI
Administrative Core
$458,807Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
Human monoclonal antibodies for prophylaxis and therapy against the new coronavirus
$458,301Michel C Nussenzweig · Rockefeller University · P01 · FY2021 · AI
Rotavirus Genome Replication and Virion Assembly
$458,225Sarah Marie McDonald Esstman · Wake Forest University · R01 · FY2024 · AI
Rotavirus Genome Replication and Virion Assembly
$458,225Sarah Marie McDonald Esstman · Wake Forest University · R01 · FY2023 · AI
COVID-19 Pandemic Vulnerability
$458,126Alison Motsinger-Reif · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV
$458,053Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Bioengineering a human microphysiological system for elucidation of viral peripheral neurotropism of RSV and SARS-CoV-2
$457,778Michael J Moore · Tulane University Of Louisiana · R21 · FY2025 · AI
CIVICS PROGRAM - SARS-CoV-2 STUDIES
$457,311Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2021 · AI
The UNC Chapel Hill Superfund Research Program (UNC-SRP)
$457,296Rebecca Fry · Univ Of North Carolina Chapel Hill · P42 · FY2020 · ES
Systems investigation of vaccine responses in B cell depleted autoimmune patients
$456,987David A. Hafler · Yale University · U19 · FY2025 · AI
Midwest AViDD Center
$456,759Reuben S Harris · University Of Minnesota · U19 · FY2022 · AI
Project 5: Pandemic Virus Helicase Inhibitors
$456,759Donghoon Chung · University Of Minnesota · U19 · FY2022 · AI
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
$456,279Britt Skaathun · University Of California, San Diego · R01 · FY2024 · MD
Coronavirus Immunoassay Core
$456,183James E Robinson · Tulane University Of Louisiana · U54 · FY2020 · CA
Novel Methods for Clinical Trials in Dementia and Cognitive Decline
$455,996Donald R Royall · University Of Texas Hlth Science Center · R01 · FY2024 · AG
Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2
$455,938Suzie H Pun · University Of Washington · U01 · FY2022 · AA
Coronavirus RNA synthesis by multicomponent protein machines
$455,907Robert N Kirchdoerfer · University Of Wisconsin-Madison · R01 · FY2021 · AI